Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Carbetocin - Ferring Pharmaceuticals

Next Previous
Drug Profile

Carbetocin - Ferring Pharmaceuticals

Alternative Names: Carbetocin Ferring; CARITEC; Duratobal; Duratocin; Lonactene; Pabal

Latest Information Update: 09 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ferring Pharmaceuticals
  • Developer Ferring Pharmaceuticals; Merck & Co; Sun Pharmaceutical Industries; World Health Organization
  • Class Antihaemorrhagics; Obesity therapies; Oxytocics; Posterior pituitary hormones
  • Mechanism of Action Oxytocin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Postpartum haemorrhage; Uterine inertia

Most Recent Events

  • 09 Jan 2026 No development reported - Phase-III for Postpartum haemorrhage in USA (IV)
  • 21 Sep 2023 Ferring Pharmaceuticals completes a phase I trial in Postpartum haemorrhage (In volunteers) in USA (IV) (NCT05924321)
  • 25 May 2023 Phase-I clinical trials in Postpartum haemorrhage (In adults, In volunteers) in USA (IV, Infusion) (NCT05924321)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top